← FDA Drug Approvals (Drugs@FDA)

ANDA213703

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2021-11-22

Drug application

FDA Application #

ANDA213703

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

MSN PHARMACEUTICALS INC

First approval

2021-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown